ductal carcinoma in situ PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ. PreCancer Atlas Attempts to Push Precision Medicine to Early-Stage Disease Premium Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form. PreludeDx Receives New York State Approval for DCIS Test The company will now be able to market the test, which algorithmically weighs molecular markers and clinical information, in all 50 US states. Topographic Single-Cell Sequencing Method Yields New Insights in Breast Cancer Evolution Premium Researchers traced clonal populations with shared copy number profiles back to their location in tissue samples, confirming patterns that may have clinical relevance. Genomic Health Publishes Second Study on Prostate Test, Expects Medicare Reimbursement by Q4 Premium With more evidence for clinical utility in the scientific literature, the company expects finalized Medicare coverage before the end of the year. Aug 4, 2015 Genomic Health Posts Flat Q2 Revenues, Misses Wall Street Estimates Dec 12, 2014 Researchers Present Data from Second Validation Study of Genomic Health Oncotype DX DCIS Test Nov 5, 2014 Genomic Health Reports 5 Percent Revenue Growth in Third Quarter Aug 13, 2014 Genomic Health Focused on Validating, Driving Adoption of Prostate Cancer, DCIS Tests Premium Aug 7, 2014 Genomic Health Reports 11 Percent Revenue Jump in Second Quarter Sep 23, 2013 Analyst Downgrades Genomic Health to Underperform May 13, 2013 Medicare to Cover Genomic Health's Oncotype DX Breast Cancer Test for DCIS May 8, 2013 With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise Premium Mar 13, 2013 Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy Premium Feb 13, 2013 After 14 Percent Revenue Bump in 2012, Genomic Health Focusing on Market Growth, Prostate Dx Launch Premium Nov 14, 2012 Genomic Health Attributes Q3 Revenue Growth to Strong International Test Adoption Premium May 9, 2012 Genomic Health Partners with OncoMed to Grow Companion Dx, NGS Reach Premium Jan 9, 2012 Genomic Health Expanding Sales Force by 20 Percent; Starts Prostate Dx Studies Nov 2, 2011 Myriad Reports 20 Percent Q1 Revenue Growth, Rising Demand for Colorectal Cancer Test Premium Aug 10, 2011 Genomic Health Focuses on Oncotype DX Tests for DCIS and Colon Cancer for Future Growth Premium Feb 16, 2011 After Profitable Year, Genomic Health to Invest in New Products, Overseas Market, Next-Gen Sequencing Premium Sep 29, 2010 Genomic Health Updates Investors on Timeline for DCIS, Colon Cancer, Prostate Cancer Tests Premium Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.